Browsing ICR Divisions by author "Julve, Maximilian"
Now showing items 1-2 of 2
-
Immunotherapy of sarcomas with modified T cells.
Mahalingam, P; Julve, M; Huang, P; Furness, AJS; Pollack, SM; et al. (LIPPINCOTT WILLIAMS & WILKINS, 2022-07-01)PURPOSE OF REVIEW: To summarize the development of modified T-cell therapies in sarcomas and discuss relevant published and ongoing clinical trials to date. RECENT FINDINGS: Numerous clinical trials are underway evaluating ... -
Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature.
Spain, L; Walls, G; Julve, M; O'Meara, K; Schmid, T; et al. (OXFORD UNIV PRESS, 2017-02-01)BACKGROUND: Treatment with immune checkpoint inhibitors (ICPi) has greatly improved survival for patients with advanced melanoma in recent years. Anti-CTLA-4 and anti-PD1 antibodies have been approved following large Phase ...